Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[No title available]
[No authors listed] [No authors listed] PMID: 39249370
Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab Therapy.
Wong R, Charilaou P, Hemperly A, Qin L, Pan Y, Mathani P, Longman R, Boland BS, Dulai PS, Holmer AK, Lukin D, Singh S, Valasek MA, Sandborn WJ, Scherl E, Vande Casteele N, Battat R. Wong R, et al. Among authors: longman r. Crohns Colitis 360. 2024 Nov 22;6(4):otae052. doi: 10.1093/crocol/otae052. eCollection 2024 Oct. Crohns Colitis 360. 2024. PMID: 39679163 Free PMC article.
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
Sands BE, Feagan BG, Peyrin-Biroulet L, Danese S, Rubin DT, Laurent O, Luo A, Nguyen DD, Lu J, Yen M, Leszczyszyn J, Kempiński R, McGovern DPB, Ma C, Ritter TE, Targan S; ARTEMIS-UC Study Group. Sands BE, et al. N Engl J Med. 2024 Sep 26;391(12):1119-1129. doi: 10.1056/NEJMoa2314076. N Engl J Med. 2024. PMID: 39321363 Clinical Trial.
Biologic therapy for ulcerative colitis associated with immune thrombocytopenia.
Nagayama M, Funayama Y, Taniguchi O, Hatano K, Oguro K, Owada J, Sakamoto H, Yano T, Longman RS, Yamamoto H. Nagayama M, et al. Among authors: longman rs. Clin J Gastroenterol. 2024 Oct;17(5):910-914. doi: 10.1007/s12328-024-02022-w. Epub 2024 Jul 31. Clin J Gastroenterol. 2024. PMID: 39085737
CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation.
Ahmed A, Joseph AM, Zhou J, Horn V, Uddin J, Lyu M, Goc J; JRI Live Cell Bank; Sockolow RE, Wing JB, Vivier E, Sakaguchi S, Sonnenberg GF. Ahmed A, et al. Nature. 2024 Jun;630(8018):976-983. doi: 10.1038/s41586-024-07537-3. Epub 2024 Jun 12. Nature. 2024. PMID: 38867048 Free PMC article.
Role of the afferent lymph as an immunological conduit to analyze tissue antigenic and inflammatory load.
Nanaware PP, Khan ZN, Clement CC, Shetty M, Mota I, Seltzer ES, Dzieciatkowska M, Gamboni F, D'Alessandro A, Ng C, Nagayama M, Lichti CF, Soni RK, Jacob B Geri, Matei I, Lyden D, Longman R, Lu TT, Wan X, Unanue ER, Stern LJ, Santambrogio L. Nanaware PP, et al. Among authors: longman r. Cell Rep. 2024 Jun 25;43(6):114311. doi: 10.1016/j.celrep.2024.114311. Epub 2024 Jun 5. Cell Rep. 2024. PMID: 38848214 Free PMC article.
211 results